Friday, July 10, 2026

pharma · Hypophosphatasia · Paroxysmal Nocturnal Hemoglobinuria

Alexion Europe SAS

News and analysis for Alexion Europe SAS on NovaPharmaNews — regulatory, clinical, and market coverage.

EU HQ
89 Employees
EMA registrant Type
Company details
Status
Public
HQ
EU
Employees
89
Programs
33
Drugs
40
Patents
0
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Alexion Europe SAS — regulatory, clinical, and market coverage.

News and analysis for Alexion Europe SAS on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Alexion Europe SAS yet.

Back to company overview →